661 related articles for article (PubMed ID: 9413186)
21. Induction of 18A2/mts1 gene expression and its effects on metastasis and cell cycle control.
Parker C; Whittaker PA; Usmani BA; Lakshmi MS; Sherbet GV
DNA Cell Biol; 1994 Oct; 13(10):1021-8. PubMed ID: 7945934
[TBL] [Abstract][Full Text] [Related]
22. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
23. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells.
Asosingh K; Günthert U; Bakkus MH; De Raeve H; Goes E; Van Riet I; Van Camp B; Vanderkerken K
Cancer Res; 2000 Jun; 60(11):3096-104. PubMed ID: 10850462
[TBL] [Abstract][Full Text] [Related]
24. Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma.
Huang GW; Mo WN; Kuang GQ; Nong HT; Wei MY; Sunagawa M; Kosugi T
Laryngoscope; 2001 Aug; 111(8):1465-71. PubMed ID: 11568585
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
26. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronidase can modulate expression of CD44.
Stern R; Shuster S; Wiley TS; Formby B
Exp Cell Res; 2001 May; 266(1):167-76. PubMed ID: 11339835
[TBL] [Abstract][Full Text] [Related]
28. CD44v6 promotes proliferation by persisting activation of MAP kinases.
Marhaba R; Bourouba M; Zöller M
Cell Signal; 2005 Aug; 17(8):961-73. PubMed ID: 15894169
[TBL] [Abstract][Full Text] [Related]
29. Expression of alpha-melanocyte stimulating hormone and the invasive ability of the B16 murine melanoma.
Zubair A; Lakshmi MS; Sherbet GV
Anticancer Res; 1992; 12(2):399-402. PubMed ID: 1580557
[TBL] [Abstract][Full Text] [Related]
30. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM
Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509
[TBL] [Abstract][Full Text] [Related]
31. Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma.
Yokoyama Y; Hiyama E; Murakami Y; Matsuura Y; Yokoyama T
Cancer; 1999 Nov; 86(9):1691-9. PubMed ID: 10547541
[TBL] [Abstract][Full Text] [Related]
32. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
Gao AC; Lou W; Sleeman JP; Isaacs JT
Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
34. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
Shimbori M; Kijima H; Sato S; Yoshida H; Sato T; Terasaki-Fukuzawa Y; Onoda N; Kanabuchi K; Abe Y; Nakamura M; Hattori M; Ohno E; Kuramoto H
Anticancer Res; 2003; 23(1A):115-21. PubMed ID: 12680202
[TBL] [Abstract][Full Text] [Related]
35. Transfection of nm23-H1 increased expression of beta-Catenin, E-Cadherin and TIMP-1 and decreased the expression of MMP-2, CD44v6 and VEGF and inhibited the metastatic potential of human non-small cell lung cancer cell line L9981.
Che G; Chen J; Liu L; Wang Y; Li L; Qin Y; Zhou Q
Neoplasma; 2006; 53(6):530-7. PubMed ID: 17167724
[TBL] [Abstract][Full Text] [Related]
36. Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.
Nobumoto A; Nagahara K; Oomizu S; Katoh S; Nishi N; Takeshita K; Niki T; Tominaga A; Yamauchi A; Hirashima M
Glycobiology; 2008 Sep; 18(9):735-44. PubMed ID: 18579572
[TBL] [Abstract][Full Text] [Related]
37. Adhesion proteins in the biology of breast cancer: contribution of CD44.
Herrera-Gayol A; Jothy S
Exp Mol Pathol; 1999 Jun; 66(2):149-56. PubMed ID: 10409443
[TBL] [Abstract][Full Text] [Related]
38. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
39. Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro.
Wu Q; Chen YQ; Chen ZM; Chen F; Su WJ
Acta Pharmacol Sin; 2002 Sep; 23(9):835-41. PubMed ID: 12230954
[TBL] [Abstract][Full Text] [Related]
40. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]